FFCP PHASE2:Hg19::chr3:18178615..18178618,+
From FANTOM5_SSTAR
Revision as of 18:38, 29 July 2015 by Autoedit (talk | contribs) (Created page with "{{FFCP |DHSsupport=supported |DPIdataset=robust |EntrezGene=NA |GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript |HGNC=NA |TSSclassifier=stron...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p@chr3:18178615..18178618, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr3:18178615..18178618, + |
Coexpression cluster: | C242_acute_Chondrocyte_myelodysplastic_granulocyte_biphenotypic_Fibroblast_stomach |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p@chr3:18178615..18178618+ |
---|
0
5
10
15
20
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cranial nerve II | 6.22e-15 | 1 |
cranial nerve | 6.22e-15 | 1 |
nerve trunk | 6.22e-15 | 1 |
nerve connecting eye with brain | 6.22e-15 | 1 |
nerve | 6.22e-15 | 1 |
retinal neural layer | 6.22e-15 | 1 |
presumptive neural retina | 6.22e-15 | 1 |
hepatopancreatic ampulla | 2.75e-14 | 1 |
extrahepatic bile duct | 2.75e-14 | 1 |
common bile duct | 2.75e-14 | 1 |
Showing 1 to 10 of 14 entries
Ontology term | p-value | n |
---|---|---|
islet cell tumor | 2.41e-14 | 1 |
endocrine pancreas cancer | 2.41e-14 | 1 |
pancreatic endocrine carcinoma | 2.41e-14 | 1 |
tubular adenocarcinoma | 8.60e-08 | 2 |
myeloid leukemia | 3.15e-07 | 31 |
carcinoma | 3.59e-07 | 106 |
organ system cancer | 8.32e-07 | 137 |
Showing 1 to 7 of 7 entries